Gubra A/S Market Cap ($772.76 Million)
Market Cap & Net Worth: Gubra A/S (GUBRA)
Gubra A/S market cap. Gubra A/S (CO:GUBRA) has a market capitalization of $772.76 Million (Dkr4.94 Billion) as of November 8, 2026. Listed on the CO stock exchange, this Denmark-based company holds position #9730 globally and #51 in its home market, demonstrating a 0.27% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Gubra A/S's stock price Dkr302.40 by its total outstanding shares 16333032 (16.33 Million). Also see how efficiently does Gubra A/S generate cash for how efficiently the company converts equity into cash flow.
Gubra A/S Market Cap History (2023–2026)
Gubra A/S market cap history from 2023 to 2026. Data shows growth from $319.43 Million to $772.76 Million (32.49% CAGR). Check GUBRA stock price and chart for real-time trading data and today's change.
Gubra A/S Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Gubra A/S's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Gubra A/S (GUBRA) equity growth momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.50x
Gubra A/S's market cap is 0.50 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.78x
Gubra A/S's market cap is 0.78 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2023 | $319.43 Million | $205.00 Million | -$44.52 Million | 1.56x | N/A |
| 2024 | $1.59 Billion | $265.74 Million | -$36.50 Million | 6.00x | N/A |
| 2025 | $1.32 Billion | $2.64 Billion | $1.69 Billion | 0.50x | 0.78x |
Competitor Companies of GUBRA by Market Capitalization
Companies near Gubra A/S in the global market cap rankings as of November 8, 2026. Also see GUBRA current and non-current assets for a full breakdown of the balance sheet.
Key companies related to Gubra A/S by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #177 globally with a market cap of $130.90 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #363 globally with a market cap of $76.14 Billion USD.
- CSL Ltd (AU:CSL): Ranked #403 globally with a market cap of $69.36 Billion USD ( AU$98.02 Billion AUD).
- Moderna Inc (NASDAQ:MRNA): Ranked #494 globally with a market cap of $54.14 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #177 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $130.90 Billion | $547.09 |
| #363 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $76.14 Billion | $904.35 |
| #403 | CSL Ltd | AU:CSL | $69.36 Billion | AU$202.04 |
| #494 | Moderna Inc | NASDAQ:MRNA | $54.14 Billion | $254.19 |
Market Capitalization of Gubra A/S (2023–2026)
Market capitalization of Gubra A/S from 2023 to today. Between 2023 and today, Gubra A/S's market cap moved from $319.43 Million to $ 772.76 Million, with a yearly change of 32.49%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Dkr772.76 Million | -41.57% |
| 2025 | Dkr1.32 Billion | -17.07% |
| 2024 | Dkr1.59 Billion | +399.20% |
| 2023 | Dkr319.43 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 7th, 2026 the market cap of Gubra A/S was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $772.76 Million USD |
| MoneyControl | $772.76 Million USD |
| MarketWatch | $772.76 Million USD |
| marketcap.company | $772.76 Million USD |
| Reuters | $772.76 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Gubra A/S
Gubra A/S, a disease-agnostic techbio company, focuses on the peptide-based drug discovery and preclinical contract research services in Europe, North America, and internationally. It operates through three segments: Preclinical Contract Research (CRO), Biotech, and Gubra Green. The company offers preclinical contract research and development services within metabolic and fibrotic diseases for th… Read more